When, Which and How to Switch: Navigating JAK Inhibitors in Myelofibrosis
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Navigating choice of JAK inhibitor (JAKi) therapy for patients with myelofibrosis who are JAKi-naïve and for those who have previously been treated with a JAKi.